These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6133830)

  • 21. Diagnosis of schizophrenia: a critical review of current diagnostic systems.
    Fenton WS; Mosher LR; Matthews SM
    Schizophr Bull; 1981; 7(3):452-76. PubMed ID: 7280573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computed tomography scans and negative symptoms in schizophrenia: chronic schizophrenics with negative symptoms and nonenlarged lateral ventricles.
    Serban G; George A; Siegel S; DeLeon M; Gaffney M
    Acta Psychiatr Scand; 1990 May; 81(5):441-7. PubMed ID: 2356766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schizophrenia research: the problem of controls.
    Buckley P; O'Callaghan E; Larkin C; Waddington JL
    Biol Psychiatry; 1992 Aug; 32(3):215-7. PubMed ID: 1420640
    [No Abstract]   [Full Text] [Related]  

  • 24. EEG power spectrum profile and structural CNS characteristics in schizophrenia.
    Gambini O; Colombo C; Macciardi F; Locatelli M; Calabrese G; Sacchetti E; Scarone S
    Biol Psychiatry; 1990 Jun; 27(12):1331-4. PubMed ID: 2364121
    [No Abstract]   [Full Text] [Related]  

  • 25. Subtype diagnosis in schizophrenia and its relation to neuropsychological and computerized tomography measures.
    Rosse RB; Schwartz BL; Mastropaolo J; Goldberg RL; Deutsch SI
    Biol Psychiatry; 1991 Jul; 30(1):63-72. PubMed ID: 1892964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study.
    Kemali D; Maj M; Galderisi S; Milici N; Salvati A
    Biol Psychiatry; 1989 Nov; 26(7):756-9. PubMed ID: 2804198
    [No Abstract]   [Full Text] [Related]  

  • 27. Family history and cerebral ventricular enlargement in schizophrenia. A case control study.
    Owen MJ; Lewis SW; Murray RM
    Br J Psychiatry; 1989 May; 154():629-34. PubMed ID: 2597855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of very poor outcome schizophrenia.
    Keefe RS; Mohs RC; Losonczy MF; Davidson M; Silverman JM; Kendler KS; Horvath TB; Nora R; Davis KL
    Am J Psychiatry; 1987 Jul; 144(7):889-95. PubMed ID: 3605400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical review of genetic studies of schizophrenia. I. Epidemiological and brain studies.
    Portin P; Alanen YO
    Acta Psychiatr Scand; 1997 Jan; 95(1):1-5. PubMed ID: 9051153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiology and expression of schizophrenia: neurobiological and psychosocial factors.
    Mirsky AF; Duncan CC
    Annu Rev Psychol; 1986; 37():291-319. PubMed ID: 3485954
    [No Abstract]   [Full Text] [Related]  

  • 31. The schizophrenia syndrome. Examples of biological tools for subclassification.
    Wyatt RJ; Potkin SG; Kleinman JE; Weinberger DR; Luchins DJ; Jeste DV
    J Nerv Ment Dis; 1981 Feb; 169(2):100-12. PubMed ID: 7009783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle:brain ratio (VBR).
    Van Horn JD; McManus IC
    Br J Psychiatry; 1992 May; 160():687-97. PubMed ID: 1534268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex uno multi: subtyping the schizophrenic syndrome.
    Jeste DV; Kleinman JE; Potkin SG; Luchins DJ; Weinberger DR
    Biol Psychiatry; 1982 Feb; 17(2):199-222. PubMed ID: 6122474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twin concordance for operationally defined schizophrenia. Confirmation of familiality and heritability.
    McGuffin P; Farmer AE; Gottesman II; Murray RM; Reveley AM
    Arch Gen Psychiatry; 1984 Jun; 41(6):541-5. PubMed ID: 6539584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor outcome and low platelet MAO activity in chronic schizophrenia.
    Bierer L; Docherty JP; Young JG; Giller E; Cohen D
    Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet monoamine oxidase activity in acute schizophrenia.
    Carpenter WT; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1975 Apr; 132(4):438-41. PubMed ID: 1119597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic constants of platelet monoamine oxidase in schizophrenia.
    Jackman HL; Meltzer HY
    Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary study on platelet monoamine oxidase in schizophrenic patients].
    Huang MS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):193-6. PubMed ID: 7261730
    [No Abstract]   [Full Text] [Related]  

  • 39. Persistent auditory hallucinations correlate with the size of the third ventricle in schizophrenic patients.
    Cullberg J; Nybäck H
    Acta Psychiatr Scand; 1992 Dec; 86(6):469-72. PubMed ID: 1471540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.